Literature DB >> 16179706

Changes in BMA policy on assisted dying.

Ann Sommerville1.   

Abstract

Entities:  

Keywords:  British Medical Association; Death and Euthanasia; Death with Dignity Act (Oregon)

Mesh：

Year:  2005        PMID： 16179706      PMCID： PMC1226256          DOI： 10.1136/bmj.331.7518.686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Oregon physicians' responses to requests for assisted suicide: a qualitative study.

Authors:  Steven K Dobscha; Ronald T Heintz; Nancy Press; Linda Ganzini
Journal:  J Palliat Med       Date:  2004-06       Impact factor: 2.947

2.  Euthanasia and other medical decisions concerning the end of life. An investigation performed upon request of the Commission of Inquiry into the Medical Practice concerning Euthanasia.

Authors:  P J van der Maas; J J van Delden; L Pijnenborg
Journal:  Health Policy       Date:  1992-09       Impact factor: 2.980

3.  Attitudes and experiences of Oregon hospice nurses and social workers regarding assisted suicide.

Authors:  Lois L Miller; Theresa A Harvath; Linda Ganzini; Elizabeth R Goy; Molly A Delorit; Ann Jackson
Journal:  Palliat Med       Date:  2004-12       Impact factor: 4.762
  3 in total
  4 in total

1.  Time to legalise assisted dying? Response from the Association for Palliative Medicine.

Authors:  David I Jeffrey
Journal:  BMJ       Date:  2005-10-08

2.  Assisted dying: the ongoing debate.

Authors:  D Harris; B Richard; P Khanna
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

3.  GPs' views on the practice of physician-assisted suicide and their role in proposed UK legalisation: a qualitative study.

Authors:  Tariq Hussain; Patrick White
Journal:  Br J Gen Pract       Date:  2009-11       Impact factor: 5.386

Review 4.  Physician-assisted suicide: a review of the literature concerning practical and clinical implications for UK doctors.

Authors:  Madelyn Hsiao-Rei Hicks
Journal:  BMC Fam Pract       Date:  2006-06-22       Impact factor: 2.497
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.